
Lucem Health offers Reveal, a family of AI care programs that help healthcare organizations target high-cost, high-prevalence diseases.
lucemhealth.comCrawled Oct 16, 2026
Disease Insights helps life sciences companies expand their total available market and optimize market access activities.
Reveal for Arrhythmias identifies cardiac risk in high-volume, high-need populations, without burdening staff or workflows.
Reveal for Colorectal Cancer uses existing data to identify patients who appear to be at higher risk for colorectal cancer.
Reveal for Liver Disease uses clinical AI to identify previously undiagnosed patients at higher statistical risk of MASH/MASLD.
The page discusses challenges preventing the healthcare industry from fully using AI models.
The blog shares healthcare AI insights from the company’s team on artificial intelligence and machine learning.
The page outlines three characteristics and capabilities clinical AI platforms need to succeed in healthcare.
Highlighting the challenges of accessing and using outcomes data for continuous improvement of clinical AI models.
Lucem Health recruits people to work with the company.
Join Lucem Health as a Development Manager, leading teams to deliver scalable technology that advances healthcare.
Join Lucem Health as an Engagement Manager, building strong partnerships and helping deliver technology that improves healthcare outcomes.
Lucem Health is assembling a board of health system leaders to guide its strategy.
The company applies clinical AI to care delivery.
Lucem Health seeks to promote the adoption of AI in healthcare.
Lucem Health deploys AI solutions to improve care delivery and outcomes.
The notice explains how the company uses collected information.
Lucem Health CEO **Sean Cassidy** receives recognition on Becker’s Hospital Review’s *Great Leaders in Healthcare 2026* list. The annual honor highlights executives driving transformative change in healthcare through proactive leadership and innovation. Cassidy’s inclusion underscores his role as a key figure shaping the industry’s future.
Apr 2026Lucem HealthNews article
Lucem Health achieves SOC 2 Type 2 certification, reinforcing its commitment to data security and system integrity for customers. The audit validates the company’s controls over data protection in digital health operations. This milestone underscores Lucem Health’s focus on maintaining trust through rigorous compliance standards.
Apr 2026Lucem HealthNews article
Lucem Health wins the **Rising Star for AI in Health Operations** at the 7th Annual Digital Health Hub Awards. The company specializes in AI-driven early disease detection, leveraging machine learning to analyze health data for predictive insights. This recognition highlights its innovation in applying AI to operational health challenges.
Oct 2025PR NewswireNews article
Lucem Health launches an AI-driven program to identify individuals at risk for presymptomatic Type 1 Diabetes (T1D). The initiative builds on its existing portfolio of AI-powered early disease detection tools, aiming to improve early diagnosis and patient outcomes. The company specializes in leveraging artificial intelligence to accelerate disease detection and enhance care delivery.
Sep 2025Yahoo FinanceNews article